Carlos Nueno - 19 Mar 2025 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role: President, International
Signature: /s/ Adam C. Vandervoort, Attorney-in-Fact
Issuer symbol: TDOC
Transactions as of: 19 Mar 2025
Net transactions value: -$69,633
Form type: 4
Filing time: 21 Mar 2025, 16:19:34 UTC
Previous filing: 04 Mar 2025
Next filing: 03 Jun 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TDOC	Common Stock	Options Exercise		+18,225	+622%		21,157	19 Mar 2025	Direct	F1
transaction	TDOC	Common Stock	Sale	$69,633	-8,266	-39%	$8.42	12,891	20 Mar 2025	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TDOC	Restricted Stock Units	Options Exercise	$0	-18,225	-33%	$0.000000	36,450	19 Mar 2025	Common Stock	18,225		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2	Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
F3	On March 19, 2024, the reporting person was granted 54,675 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025.